
Top-performing medical device sales leader with a proven record of driving the adoption of disruptive technologies across complex hospital systems. Nationally ranked (Top 10% 2021–2025), with experience leading enterprise-level conversions, executive stakeholder alignment, and clinical change management. Currently, I direct a $12M portfolio, consistently delivering over $1M in incremental annual growth. Well-positioned to support Procept BioRobotics’ mission by accelerating the adoption of AQUABEAM robotic therapy through strategic account leadership, surgeon engagement, and value-based selling.